Position in AZN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,296,242
+$16,876 QoQ
Shares Held
6,836
+5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#606
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avestar Capital, LLC holds $29,224,901 across 12 Drug Manufacturers - General names. AZN ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,456 | $10,142,380 | |
| 2 | JNJ |
Johnson & Johnson
|
18,732 | $4,757,366 | |
| 3 | ABBV |
AbbVie Inc.
|
14,349 | $3,610,782 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,418 | $2,579,610 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,444 | $2,370,054 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
6,836 | $1,296,242 | |
| 7 | AMGN |
Amgen Inc
|
3,577 | $1,295,303 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,003 | $922,092 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,296,242 | 6,836 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,279,366 | 6,487 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||